Huntsville, AL – According to filings with the U.S. Securities and Exchange Commission, GeneCapture is raising $6,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Peggy Sammon played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About GeneCapture
Detecting Pathogens Takes Too Long. Our patented CAPTURE (Confirm Active Pathogens Through Unamplified RNA Expression) technology solves this problem, and we are now developing a portable instrument to screen for hundreds of pathogens within an hour for less than $20. GeneCaptures unique approach to disease diagnostics uses rapid RNA-based technology to bring infection detection to the Point of Care; whether that’s a hospital bed, an airport, a cruise ship, or a battlefield.

To learn more about GeneCapture, visit http://www.genecapture.com/

Contact:
Peggy Sammon, Chief Executive Officer
256-783-4506
psammon@genecapture.com
https://www.linkedin.com/in/peggy-l-sammon-a4511862/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved